The exosome diagnostic and therapeutic market is projected to grow at a CAGR of 9.1% from 2024 to 2034. Market valuation will increase from USD 88.56 million in 2024 to USD 211.6 million by 2034.

Over 130 experts to explore the latest developments in artificial intelligence, cybersecurity, and innovations in training ...

Sanford C. Bernstein upgraded shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) from a market perform rating to an ...

From San Diego to Washington, D.C., Oliver Cottrell’s invention won prestigious awards in the past year. And now he has a new ...

As the new Congress and a new administration start up, the fate of FDA-issued regulations on laboratory-developed tests (LDTs ...

Shares of Thermo Fisher Scientific Inc. TMO shed 0.48% to $542.31 Friday, on what proved to be an all-around poor trading ...

She joins a team of experts at ON Partners, including partners Nina McMaster and Suzanne Zebedee, Ph.D., both recognized for ...

Browse 194 market data Tables and 45 Figures spread through 226 Pages and in-depth TOC on "Slide Stainer Market by Product ...

Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. | For nearly a decade, Eli Lilly has been ...

LGC has announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and ...

Oncology Accounts for the Highest Revenue-Grossing Application, while Consumer Genomics is Predicted to Grow at the Highest ...